Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that lacks effective treatment options. Genervon has discovered and developed GM604 (GM6) as a potential ALS therapy. GM6 has been modeled upon an insulin receptor tyrosine kinase binding motoneuronotrophic factor within the developing central nervous system. https://www.alarecre.com/NFL-Atlanta-Falcons-Double-Vision-iPhone-13-Pro-MagSafe-Case-p92343/